Reply to: "Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?"
- PMID: 33915237
- DOI: 10.1016/j.jhep.2021.04.028
Reply to: "Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?"
Conflict of interest statement
Conflict of interest DB: Consultant: Bayer Healthcare, Boston Scientific, Shionogi. Lectures: Falk Foundation. RK: Consultant: Boston Scientific, Bristol-Myers Squibb, Guerbet, Roche, and SIRTEX. Lectures: BTG, Guerbet, Ipsen, SIRTEX, MSD Sharp & Dohme. MS: Consultant: Bayer Healthcare, L.W.Gore Lectures: Falk Foundation. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26. J Hepatol. 2021. PMID: 33508376
-
Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?J Hepatol. 2021 Aug;75(2):487-489. doi: 10.1016/j.jhep.2021.02.031. Epub 2021 Mar 12. J Hepatol. 2021. PMID: 33716088 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
